2-[[4-[(1-Carboxy-2-hydroxyethyl)amino]-6-[2-(4-sulfamoylphenyl)ethylamino]-1,3,5-triazin-2-yl]amino]-3-hydroxypropanoic acid

InChIKey	`VKDFALPNJNFOKS-UHFFFAOYSA-N`
Compound Name	2-[[4-[(1-Carboxy-2-hydroxyethyl)amino]-6-[2-(4-sulfamoylphenyl)ethylamino]-1,3,5-triazin-2-yl]amino]-3-hydroxypropanoic acid
Canonical SMILES	`NS(=O)(=O)c1ccc(CCNc2nc(NC(CO)C(=O)O)nc(NC(CO)C(=O)O)n2)cc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	7.38
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.2	Ki	ChEMBL;BindingDB
Q9ULX7	CA14	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
Q16790	CA9	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.3	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.3	pIC50	TTD_MultiTarget